Leon from Norway

Registered at the short selling broker Prime XBT, 4 minutes ago.

» Try Prime XBT you too
Don't show again

C4 Therapeutics, Inc. (CCCC) shares information

C4 Therapeutics Inc


24h Change

0.89 %

CCCC

Live rate: Market closed

Stock data per Friday 25 Nov, 2022

CCCC
NASDAQ
7.86
7.81
7.93
0.07 (+ 0.89%)
US Market is closed

Live Stock price in graph for C4 Therapeutics Inc (CCCC)

  • Latest Volume

    444,069 (19.66 %)

  • Volume prev. day

    371,101

  • Avg. daily volume

    474,734

  • Market cap

    388,229,066

  • P/E ratio

    n/a

  • Today high

    8.05 USD

  • Today low

    6.705 USD

  • 52 week high

    38.05 USD

  • 52 week low

    4.84 USD

  • YTD Change

    n/a

Quick links

 

Latest news about C4 Therapeutics Inc

Below you can find the most recent news posts about C4 Therapeutics Inc, primarily from US and UK based news sources.

C4 Therapeutics”s Return On Capital Employed Overview

Wednesday, 23 November 2022, 15:50:42
Benzinga Pro data, C4 Therapeutics (NASDAQ: CCCC ) reported Q3 sales of $6.75 million. Earnings fell to a loss of $31.96 million, resulting in a 16.58% decrease from last quarter. C4 Therapeutics collected $13.83 million in revenue during Q2, but reported earnings showed a $27.41 million loss. What Is Return On Capital Employed? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of … Full story available on Benzinga.com
— Benzinga


Was anything positive for C4 Therapeutics Inc. (CCCC) stock last session?

Wednesday, 16 November 2022, 14:16:00
As of Tuesday, C4 Therapeutics Inc.’s (NASDAQ:CCCC) stock closed at $9.72, up from $9.11 the previous day. While C4 Therapeutics Inc. has overperformed by 6.70%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CCCC fell by -76.69%, with highs and lows ranging from $43.61 to $4.84, […]
— US Post News


Do investors need to be concerned about C4 Therapeutics Inc. (CCCC)?

Tuesday, 8 November 2022, 17:00:00
While C4 Therapeutics Inc. has underperformed by -0.56%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CCCC fell by -80.38%, with highs and lows ranging from $48.75 to $4.84, whereas the simple moving average fell by -30.91% in the last 200 days. On November 04, 2022, […]
— US Post News


C4 Therapeutics PT Lowered to $24 at UBS

Friday, 4 November 2022, 14:05:18
https://www.investing.com/news/pro/c4-therapeutics-pt-lowered-to-24-at-ubs-432SI-2933132
— Investing.com


UPDATE: JPMorgan Downgrades C4 Therapeutics to Neutral

Friday, 4 November 2022, 11:14:10
https://www.investing.com/news/pro/jpmorgan-downgrades-c4-therapeutics-to-neutral-432SI-2932211
— Investing.com


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have CCCC available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.